FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to a pharmaceutical implant designated for sustained-release of medicinal agents distributed in resolving polymer consisting of bound microparticles for maintenance of required form of polymer being without polymer caking. Proposed implant is administrated in the body patient wherein it is decomposed for separate microparticles for a definite period after intake. Also, invention relates to a method for sustained-release of drug in the patient body that involves administration of implant into the patient body and to methods for preparing this pharmaceutical implant (variants). Invention provides continuous sustained-release of drug from implant into the patient body for a long time.
EFFECT: improved preparing method, improved and valuable properties of implant.
40 cl, 9 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
THERAPEUTIC AND DIAGNOSTIC DRUG AND BIOLOGICALLY ACTIVE SUBSTANCE CARRIER AND APPLICATION THEREOF FOR MAKING DRUGS AND METHOD OF REGULATED CONTROLLED DRUG OR BIOLOGICALLY ACTIVE SUBSTANCE DELIVERY WITH REGULATED DESORPTION | 2006 |
|
RU2373957C2 |
EYE IMPLANTAT PREPARED BY DOUBLE EXTRUSION METHOD | 2005 |
|
RU2389479C2 |
MICROPARTICLES AND METHOD OF THEIR PREPARING | 1997 |
|
RU2201214C2 |
MEDICINAL AGENTS WITH CONTROLLED RELEASE BASED ON BLOCK-COPOLYMERS | 2006 |
|
RU2409348C2 |
CORTICOSTEROIDS FOR JOINT PAIN TREATMENT | 2011 |
|
RU2642279C2 |
RISPERIDONE-CONTAINING MICROCAPSULES, PHARMACEUTICAL COMPOSITION AND METHODS OF THEIR MAKING | 1994 |
|
RU2178695C2 |
PROLONGED-RELEASE PHARMACEUTICAL COMPOSITIONS FOR PEPTIDE DELIVERY | 2007 |
|
RU2456018C2 |
PROLONGED ACTION THERAPEUTIC AGENT BASED ON ANASTROZOLE | 2017 |
|
RU2659689C1 |
DEGRADABLE REMOVABLE IMPLANT FOR CONTINUOUS RELEASE OF ACTIVE COMPOUND | 2010 |
|
RU2593790C2 |
SUNITINIB-BASED COMPOSITIONS AND METHODS FOR USING THEM FOR TREATING EYE DISEASES | 2015 |
|
RU2729731C2 |
Authors
Dates
2006-03-27—Published
2001-01-24—Filed